Fingerprint
Dive into the research topics of 'A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: An Eastern Cooperative Oncology Group Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically